2008

Florida: Orange County Sued Over Tainted AIDS Pharmacy Bid Process by AHF: Business Wire - October 6, 2008; -- Non-profit AIDS Service Provider Says Orange County Officials Violated Federal Regulations and Committed Repeated Illegal Acts; Group Claims County Places Bureaucracy Above Patient Needs ORLANDO, Fla.--AIDS Healthcare Foundation: WHAT: Press Conference--Filing of LEGAL COMPLAINT by AHF Pharmacy Against Orange County
BioAlliance Acts in Favour of Patients' Quality of Life in Connection with the French National Event 'La Semaine du Gout': Business Wire - October 6, 2008; PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, announced its collaboration to the book entitled Rediscover the pleasure of food , containing culinary recommendations and recipes targeted at cancer p
Macy's Celebrates Milestone 150th Birthday on October 28, 2008: Business Wire - October 6, 2008; -- Month-Long Celebration Includes National Rollout of Signature Fashion Show, New Orleans Store Openings, a Customer Shopping Event and a Fashion Industry Gala NEW YORK--Macy s (NYSE:M) is celebrating an epic milestone this month as the famous retailer marks its 150th birthday on October 28. A local retail store turne
AHF Steps Up "Shame on Abbott" Advocacy Campaign in Abbott Park, IL: Business Wire - October 6, 2008; -- Print Ad-which Appeared in Saturday s Lake County News-Sun-Focuses on Abbott CEO Miles D. White and His Company s Terrible Record on AIDS -- Campaign Highlights Abbott s Latest Shameful Act: Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexi
Avexa Bolsters Board of Directors and Appoints New Chairman: Business Wire - October 6, 2008; MELBOURNE, Australia--Avexa Limited (ASX:AVX) today announced that Nathan Drona will replace Stephen Cooper as Chairman of the Board while David Bottomley and Alan Boyd represent new additions to the Board. Mr. Cooper, who was serving as interim Chairman, will be stepping down from the Board to focus on his activities
NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects: Business Wire - October 6, 2008; -- Temporary Stock Symbol Change Will Be Reversed WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), commented on the recent and temporary change of its quotation symbol from NNVC.OB to NNVCE.OB. The E reflects that the Company has not yet filed its Form 10-KSB, annual report to shareholders. The
Examine Thailand's Pharmaceuticals and Healthcare Industry with this Comprehensive Report Q3 2008: Business Wire - October 3, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/32f8ba/thailand_pharm aceu) has announced the addition of the Thailand Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Thailand Pharmaceuticals and Healthcare Report provides independent forecasts and competi
Examine Zimbabwe's Pharmaceuticals and Healthcare Industry with this Comprehensive Report, Q3 2008: Business Wire - October 3, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/867691/zimbabwe_pharm aceu) has announced the addition of the Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competi
Standard & Poor's Initiates Factual Stock Report Coverage on Mymetics Corporation: Business Wire - October 2, 2008; NEW YORK--Standard & Poor s announced today that it has commenced Factual Stock Report coverage on Mymetics Corporation. Mymetics Corporation (OTCBB:MYMX), is a biotechnology company focused on developing prophylactic vaccines, presently focusing on vaccines against the human immunodeficiency virus (HIV/AIDS) and m
Progenics Announces Progress and Presentations in HIV Therapy Program: Business Wire - October 2, 2008; -- Enrollment for PRO 140 phase 2 clinical studies completed -- -- Interim phase 2 results for intravenous form of PRO 140 to be presented at late-breaker ICAAC session -- -- PRO 140 phase 1b clinical study results published in Journal of Infectious Diseases -- TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (Nasdaq:
GenVec Receives Third-Year Funding from NIAID for HIV Vaccine Contract: Business Wire - October 2, 2008; GAITHERSBURG, Md.--GenVec, Inc. (Nasdaq:GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its second option period (year three) under a previously announced, five-year contract with GenVec valued at up to $52 millio
U.S. Food & Drug Administration Approved the use of REYATAZ(R) (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients: Business Wire - October 1, 2008; PRINCETON, N.J.-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration ( FDA ) approved the use of REYATAZ(R) ( atazanavir sulfate) 300 mg once-daily boosted with ritonavir 1
VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation: U.S. Government Grant Supports Preclinical and Clinical Development, Manufacturing and Other Activities for VGX's HIV DNA Vaccine Candidate: Business Wire - October 1, 2008; BLUE BELL, Pa.--VGX Pharmaceuticals (VGX), a developer of DNA vaccines against cancer and infectious diseases that has entered into a definitive merger agreement with Inovio Biomedical (AMEX:INO - News), announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National
Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets (Ehrlich II) in Nürnberg, Germany: Business Wire - October 1, 2008; SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced the Company s President and CEO, Dr. Franco Lori, will be speaking at the prestigious 2nd World Conference on Magic Bullets (Ehrlich II) in Nürnberg, Germany on Saturday, October 4th 2008. Dr. Lori will address the international conference on the su
AHF Applauds Schwarzenegger for Signing First-in-the-Nation HIV Testing Coverage Bill: Business Wire - September 30, 2008; -- AB 1894 (Krekorian, D-Burbank), Sponsored by AHF, Compels Insurers Operating in California to Cover Costs of Routine HIV Tests -- Legislation Will Help California Comply with CDC s Updated 2006 HIV Testing Guidelines Recommending Routine HIV Screening for All Individuals Ages 13 to 65 --(BUSINESS WIRE)--AIDS Healthc
Incyte to Present at JMP Securities Third Annual Healthcare Focus Conference: Business Wire - September 30, 2008; WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) announced today it will present at the JMP Securities Third Annual Healthcare Focus Conference on Monday, October 6, 2008 at 11:00 a.m. (Eastern Time). Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and dis
Allion Healthcare to Present at Maxim Group Growth Conference: Business Wire - September 30, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Maxim Group Growth Conference at 8:30 a.m. (Eastern) on Tuesday, October 7, 2008 at the Grand Hyatt Hotel in New York, New York. Mike Moran, Allion s Chairman, President and Chief Executive Officer and Russ Fichera, Chief Finan
Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development: Business Wire - September 30, 2008; SEATTLE--Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company s Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development. Dr. Fletcher was appointe
OraSure Applauds Congress for Passing Legislation to Enable Routine HIV Testing Throughout the U.S. Veterans Health Care System: Business Wire - September 29, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today issued a statement applauding the U.S. Congress for passage of The Veterans Mental Health and Other Care Improvements Act of 2008 (S. 2162). The bill includes a provision that repeals the 1988 Veterans Benefits
Aethlon Medical Initiates First Clinical Study Of a Medical Device to Treat HIV/AIDS Patients: Business Wire - September 29, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has initiated patient enrollment in the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). The device, known as the Aethlon Hemopurifier
Schwarzenegger Signs Crucial California HIV Testing Bill: Targeting Repeat Testers (AB 2899, Portantino, D-Pasadena): Business Wire - September 29, 2008; -- Bill Streamlines HIV Counseling and Education Services for People Who Have Previously Tested and Received Such Counseling and Preventive Education Before SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised Governor Arnold S
Q3 2008 Report for the Indonesia Pharmaceuticals and Healthcare Industry: Business Wire - September 28, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/16dd16/indonesia-pharmace) has announced the addition of the Indonesia Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Indonesia has a rapidly growing population of 240 million and has witnessed many of its neighbo
AHF Advocacy Spurs GSK to Suspend Fear-Mongering AIDS Drug Ads: Business Wire - September 26, 2008; -- AHF Runs Pieces Headlined GSK: Worst Drug Ads Ever. The Issue Prompts Articles in the Wall Street Journal and Philadelphia Inquirer; Subsequently, Company Pulls Ads -- AHF and Others Believe Controversial Ad Campaign Was an Attempt by GSK to Maintain Market Share, to Detriment of Patient Health LOS ANGELES--AIDS Hea
An Industry Analysis of the Anti-Infectives Market Outlook to 2013: Examine the Competitive Landscape, a Pipeline Analysis & Growth Opportunities: Business Wire - September 26, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/a7d0e3/the_antiinfect ive) has announced the addition of the The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities report to their offering. The market for anti-infectives related di
ISENTRESS(TM) (raltegravir) Awarded Prix Galien USA Top Honor: Business Wire - September 25, 2008; WHITEHOUSE STATION, N.J.--ISENTRESS(TM) (raltegravir), Merck s medicine for HIV/AIDS, received the Prix Galien USA 2008 Award for Best Pharmaceutical Agent, Merck & Co. , Inc. announced today. We are delighted that more than a decade of work by Merck researchers has been recognized with such a prestigious award, s
AHF Urges Passage of 'Stop AIDS in Prison Act': As H.R. 1943 (Waters, D-CA) Goes Before Senate Judiciary Committee Today, Nation's Largest AIDS Organization Calls Bill "Urgent Lifesaving Legislation": Business Wire - September 25, 2008; WASHINGTON -- AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which currently provides treatment, care and support services to more than 80,000 individuals in 22 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, urges the passage of the Stop AIDS in
Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical Data Exploring Twice-Daily Dosing Regimens: Business Wire - September 24, 2008; CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that key data on sustained viral response (SVR) rates in both treatment-naive and treatment-failure genotype 1 hepatitis C (HCV) patients who received telaprevir-based treatment regimens will be presented at the 59th Annual Meeting of
AHF Calls on Iran to Release Two Respected AIDS Physicians Held Since June: Business Wire - September 23, 2008; -- Dr. Kamiar Alaei and Dr. Arash Alaei-Two Brothers Internationally Known for their Work on HIV/AIDS-Have Been Detained Without Charge By Iranian Officials Since June 2008 -- US Largest AIDS Group Joins International Call to Press Iranian President Mahmoud Ahmadinejad, Who is to Speak Today at the UN General Assembly
Use of AIDS Test Can Prolong Life While Saving Money, Stanford Study Finds: Business Wire - September 22, 2008; STANFORD, Calif.--A simple test given to HIV/AIDS patients in southern Africa could extend their lives by nearly a year and save health-care costs at the same time, according to a new study by researchers at the Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care System. The technique,
UCSF Celebrates 45th Anniversary of Transplant Service: Business Wire - September 19, 2008; SAN FRANCISCO--As a world leader in organ transplantation, UCSF will celebrate its 45th year of transplantation with a week of exciting workshops, lectures and forums. Virtually every single person in this country knows someone who has end-stage organ disease and who could benefit from transplantation, said Nancy Asche
No-Fee Quick Collect Money Transfer Services to Benefit Humanitarian Relief Organization in Haiti: Public May Donate to CARE Through Western Union No-Fee Service: Business Wire - September 19, 2008; SUNRISE, Fla.--Western Union, a leading provider of global money-transfer services, announced today it has established a Quick Collect account that will allow the public in the U.S. to donate to CARE for disaster relief efforts currently underway in Haiti . Individuals and corporations wishing to donate to disaster rel
This Essential German Pharmaceuticals and Healthcare Report is Available Now: Business Wire - September 19, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/6766fb/germany_pharma ceut) has announced the addition of the Germany Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Our Germany Pharmaceuticals and Healthcare Report provides independent forecasts and competitive
OraSure Technologies to Participate at the 2008 UBS Global Life Sciences Conference: Business Wire - September 18, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the 2008 UBS Global Life Sciences Conference in New York City at approximately 2:30pm Eastern Time, (11:30am Pacific Time) on Tuesday, Septem
Press Conference to Announce September 18, 2008 as the Launch of the First Annual National HIV/AIDS and Aging Awareness Day: Business Wire - September 18, 2008; FT. LAUDERDALE, Fla.--September 18, 2008 marks the launch of a new national awareness initiative of The AIDS Institute entitled National HIV/AIDS and Aging Awareness Day (NHAAAD). This national campaign will highlight the complex issues related to HIV prevention, care and treatment for aging populations in the
Kenneth Cole To Receive Humanitarian Designer Award at Islands of the World Fashion Week: Business Wire - September 17, 2008; NASSAU, Bahamas--Owen Bethel, President of Mode Iles, Ltd., founder and organizer of Islands of the World Fashion Week, announced today that the Humanitarian Designer Award will be presented to Kenneth Cole and Kenneth Cole Productions, Inc. during Islands of the World Fashion Week in November, 2008. Mr. Bethel stated
Aethlon Medical Reports Promising Treatment Results In Hepatitis-C Infected Patients: Business Wire - September 17, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced preliminary data of Hepatitis-C (HCV) infected patients treated with the Aethlon Hemopurifier(R), a medical device designed to assist the immune response in combating infectious disease. The HCV treated patients were among end-stage renal disease (kidney di
'Shame on Abbott': AIDS Healthcare Foundation's New Ad: Campaign Blasts Drug Company for Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexico Than in Other Middle-Income Countries: Business Wire - September 16, 2008; LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments globally, AIDS Healthcare Foundation (AHF), which operates three free treatment clinics in Mexico (Puerto Vallarta, Cancun and Tuxtla Gutierrez) today unveiled a new print advertisement criticizing
BioAlliance Pharma Announces Participation in the MidCap Event on September 29 and 30, 2008: Business Wire - September 16, 2008; -- MidCap Event PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris: FR0010095596-BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced that it will participate in the MidCap Event, a forum dedicated to meetings between i
Remarks by President Bush and President Kufuor of Ghana in Joint Statement: Business Wire - September 15, 2008; WASHINGTON--Rose Garden 11:00 A.M. EDT PRESIDENT BUSH: Good morning. I m pleased to be here with my friend, the President of Ghana , John Kufuor of Ghana. We just had a very good discussion and before I summarize it I do want to say a word about the U.S. economy. I know Americans are concerned about the adjustments tha
Experts Call on Governor Schwarzenegger to Sign AB 1894 to Prevent the Spread of HIV/AIDS: California Poised to Lead the Nation in Setting Medical Standard in HIV/AIDS Prevention: Business Wire - September 11, 2008; SACRAMENTO, Calif.--Today, California s leading HIV/AIDS and healthcare experts called on the Governor to sign AB 1894 (authored by Assembly Member Paul Krekorian) in light of new data from the Centers for Disease Control and Prevention (CDC). This August, the CDC announced that the United States has been under-est
BioScrip and United Healthcare to Exit Specialty Services Agreement in 2009: Business Wire - September 11, 2008; -- Financial Impact Estimated at $2.0 Million for 2009 ELMSFORD, N.Y.--BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE: UHG) company, has notified the Company of its intention to internalize services for HIV/AIDS and Solid Organ Transplant drugs for United members effecti
New Study Building off Viral Genetics' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS: Business Wire - September 10, 2008; -- Gift from Undisclosed Source Will Go towards Study Which Researchers Hope Will Reconcile Long-Standing Debate over Treatment of Lyme Disease AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has completed an initial st
Thousands of Children Benefit from the Association of Hole in the Wall Camps: Business Wire - September 10, 2008; NEW HAVEN, Conn.--The Association of Hole in the Wall Camps had another successful camp season, largely exceeding the number of children who attended camp last year. This summer, five camps in the United States and five camps in Europe, as well as programs in Africa and Southeast Asia, provided opportunities for childr
Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis(TM) Personalized Immunotherapy Platform: Business Wire - September 10, 2008; -- AGS-003 to be tested in combination with sunitinib DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a trial of its AGS-003 therapy, in combination with sunitinib, for the treatment of newly diagnosed advanced renal cell carcinoma (RCC). AGS-003 is a product of the Company s Arcelis(TM) tec
Altor BioScience Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital: Business Wire - September 10, 2008; MIRAMAR, Fla.--Altor BioScience Corporation (Altor) today announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by HIV and Hepatitis C Virus (HCV). The license has resulte
American Express Announces Top 25 Projects Competing for $2.5 Million in Funding Through Members Project(R): Business Wire - September 9, 2008; -- Cardmember Vote Will Determine Which Projects Advance to Top Five NEW YORK--American Express unveiled today the top 25 projects selected as semi-finalists for Members Project (www.membersproject.com), the online initiative that invites Cardmembers to come together to submit, discuss and vote for projects to make a p
The Tech Museum of Innovation Announces 2008 Tech Awards Laureates: Business Wire - September 9, 2008; -- Twenty-Five Innovators From Around the World Recognized for Developing and Applying Technology to Benefit Humanity SAN JOSE, Calif.--The Tech Awards, presented by Applied Materials (Nasdaq:AMAT), and a signature program of The Tech Museum of Innovation, today announced the 2008 Tech Awards Laureates, 25 global innov
Remarks by the First Lady at a "ONE" Campaign Event: Business Wire - September 4, 2008; MINNEAPOLIS--Minneapolis Convention Center 3:06 P.M. CDT MRS. BUSH: Thank you very much, Cindy. Thanks a lot. Thank you all. Thanks to everybody who s come out today to put these kits together. Thank you all. Thanks so much. I am very happy to be here today to be with all of you as we put these kits together for World
Aethlon Medical Releases Shareholder Letter: Business Wire - September 4, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the first clinical use of our Hemopurifier(R) in HIV-infected
M A C AIDS Fund, Fergie Spearhead Global Youth Initiative for HIV Prevention: Business Wire - September 4, 2008; -- Multi-Million Dollar Campaign Aimed at Combatting Skyrocketing HIV Infection Rate among 15-24-Year-Olds NEW YORK--Yesterday, in New York City, M A C VIVA GLAM VI spokesperson, Fergie, announced 11 new grants from the M A C AIDS Fund (MAF) aimed at preventing the spread of HIV among young people, ages 15-24, who acco
Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS: Business Wire - September 4, 2008; MELBOURNE, Australia--Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS. The product i
Press Availability by the First Lady: Business Wire - September 2, 2008; MINNEAPOLIS--Crowne Plaza Hotel St. Paul, Minnesota September 1, 2008 8:41 A.M. CDT Q Tell me the challenge of balancing this convention with what s going on in the Gulf Coast. MRS. BUSH: Well, I think, you know, we ll just see how it goes. Obviously everybody here understands. I mean, people are disappointed, the dele
Walter Reed Evaluation Concludes OraQuick(R) HCV Test is Preferred Over Other Rapid Tests: Business Wire - September 2, 2008; - OraQuick(R) HCV Test Found to Have Higher Sensitivity and Specificity Than Other Rapid HCV Tests - BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that an evaluation by the Walter Reed Army Institute of Research of the OraQuick(R) HCV Test, currentl
Remarks by President Bush and President Kikwete of the United Republic of Tanzania after Meeting: Business Wire - August 29, 2008; WASHINGTON--Oval Office 11:50 A.M. EDT PRESIDENT BUSH: It is such an honor to welcome a man I ve come to admire a lot to the Oval Office, President Kikwete of Tanzania . He comes representing a great country. He also comes representing the African Union. And therefore, we ve had a wide-ranging discussion about our bila
California Law to Compel Insurers to Cover Routine HIV Tests Is First in Nation: Business Wire - August 29, 2008; -- AB 1894 (Krekorian, D-Burbank), Will Advance Fight Against HIV/AIDS in California -- Following CDC s Recent Announcement of Alarming 40% Annual Increase in HIV Incidence in the US, Legislation Will Help Communities Meet CDC s Previous 2006 Guidelines Recommending Routine HIV Testing in Clinical and Health Care Setti
Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology: Business Wire - August 27, 2008; REDWOOD CITY, Calif. -- Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it has been awarded a 2-year, $3.4 million grant from the United States Department of Defense1 to develop technology to advance vaccine research and development. Under
AHF Blasts GlaxoSmithKline Print Ads That Promote Fear of HIV Treatment: Business Wire - August 25, 2008; As Reported in Today s Wall Street Journal, AHF Says Recent GSK Ad Campaign is Attempt to Maintain Market Share without Regard for Patient Health; Asks HHS to Step Up Oversight in Light of FDA s Failure to Do So LOS ANGELES -- AIDS Healthcare Foundation (AHF), the largest non-profit AIDS healthcare provider in the
Minnesota AIDS Project Highlights the Need for a National HIV Prevention Strategy at the Republican and Democratic National Conventions - Will distribute safer sex kits at local bars with education information included during RNC: Business Wire - August 25, 2008; MINNEAPOLIS -- Contrary to what many Americans may believe, AIDS is a growing public health threat not only overseas, but right here at home. Over the next two weeks, political leaders from both parties will discuss a variety of important issues facing the United States . The Minnesota AIDS Project, the leading source
Greenberg Glusker Attorney Rachel Wilkes Lauded for Pro Bono Asylum Victory - Undeterred Greenberg Glusker Attorney Prevents Deportation of Abuse Victim to Mexico: Business Wire - August 22, 2008; LOS ANGELES -- As a result of the determination of a young Greenberg Glusker litigator, a physical and sexual abuse victim facing grave danger if returned to her native Mexico obtained an order from a U.S. Immigration judge granting asylum in the United States . The ruling is the outcome of a multijurisdictional, ye
BioAlliance Pharma Announces the Grant of Its Main Patent on The Lauriad(R) Technology in Europe: Business Wire - August 22, 2008; The patent has been validated in the main European countries and the opposition period has now expired PARIS -- Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant of its main patent on
LinkMed: Qiagen launches Olerup SSP AB's new test for detecting adverse reactions to HIV-medicine in the EU: Business Wire - August 22, 2008; LinkMed s wholly owned subsidiary Olerup SSP AB has developed a new test that detects genetic variations in the Human Leucocyte Antigen (HLA) system that indicate risk for severe adverse reactions to Abacavir in HIV patients. The test is marketed and sold by Qiagen. Experts expect more tests for similar markers in the
Tegan Quin and Augusten Burroughs Co-Headline Housing Works Benefit for SPIN.com Sept 4, in NYC: Business Wire - August 21, 2008; -- New Tegan and Sara Video on the Way; Tegan to Appear in Against Me! Video BURBANK, Calif.--As previously reported, singer/songwriter Tegan Quin from acclaimed Canadian band Tegan and Sara and author Augusten Burroughs (Running With Scissors; A Wolf at the Table) will co-headline SPIN.com s Liner Notes, an event at H
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious IHV Meeting: Business Wire - August 19, 2008; Team Welcomes Attendees to Poster Session to Discuss Findings, Which Could Lead to Inexpensive, Effective HIV Therapy, and May Be Applicable to Autoimmune Diseases AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theor
ProLink Announces Promotional and Event Partnerships with River Oaks US Men's Clay Court Championship; and Elton John & Billie Jean King Charity Event: Business Wire - August 19, 2008; -- Firm to Launch Nationwide Series Following US Open featuring Sampras, Navratilova, Roddick, Kournikova, Bryan Brothers and More AUSTIN, Texas--ProLink Sports + Entertainment + Media (ProLink) announced today that it will serve as an event partner for two of tennis premier events: the 2008 World Team Tennis All-Star
iTherX Pharmaceuticals Appoints Scientific and Clinical Advisory Board for Hepatitis C Antiviral Drugs: Business Wire - August 9, 2008; SAN DIEGO--iTherX Pharmaceuticals Inc, a privately held biopharmaceutical company, today announced that it has appointed a Scientific and Clinical Advisory Board to assist the company in the development of its novel therapeutic agents for Hepatitis C. iTherX is pioneering the introduction of a novel class of antivirals
Mattel Children's Foundation Continues Signature Partner Collaboration with Total Donation of $2.1 Millon to Six Charities: Business Wire - August 18, 2008; -- Mattel commits 2 percent of annual pre-tax profit to global philanthropic giving. EL SEGUNDO, Calif.--Highlighting a tradition of making a meaningful difference in the lives of children, Mattel, Inc. [NYSE: MAT] today announced the continuation of its commitment to the company s six Signature Partners. In 2008, Matt
Shuyuan Zhang Joins VIRxSYS as Senior Director of Production: Business Wire - August 18, 2008; GAITHERSBURG, Md.--VIRxSYS Corporation announced today that Shuyuan Zhang, PhD, has joined the company as Senior Director of Production. Zhang will focus on the development and late stage GMP manufacture of lentiviral vectors and ex vivo patient CD4 T cell transduction and expansion for HIV treatment. The Company s fir
Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles: inancial Capital Markets M.A.D. MAX Equity Conference: Business Wire - August 15, 2008; LAKE LAS VEGAS, Nev.--The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D. MAX Equity Conference presenter profiles. For in-depth information about the event, visit
224,000 Californians Sign Petition Urging the Governor and Legislature to Rescind Medi-Cal Cuts: Medi-Cal Patients Are Losing Access to Needed Medication: Business Wire - August 14, 2008; SACRAMENTO, Calif.--The ten percent Medi-Cal provider cuts that went into effect on July 1, 2008 have already created hardships throughout California for pharmacists and the patients they serve. More and more pharmacies have been forced to stop filling Medi-Cal prescriptions because pharmacies lose money on nearly ever
amfAR Announces Appointment of Bradley Jensen as New CFO: Business Wire - August 14, 2008; -- With extensive experience in global finance, Jensen will help the foundation expand its international presence NEW YORK--amfAR, The Foundation for AIDS Research, has appointed Bradley Jensen as its new chief financial officer, amfAR CEO Kevin Robert Frost announced today. Jensen comes to amfAR from the Global Allian
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN): Business Wire - August 14, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has reported initial positive safety data from its Phase IIb/IIIa clinical study of RPI-78M for treating
Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research: Business Wire - August 14, 2008; -- DNA Vaccine Delivery Technology Shows Promise in Inducing Stronger Immune Responses SAN DIEGO--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today it has expanded its research license with the
Gamma Mu Foundation Awards $129,550 in Gay & Lesbian Community Service Grants and Scholarships: Business Wire - August 13, 2008; NEW YORK--Gamma Mu Foundation today announced the award of more than $129,000 in community service & public education grants and scholarships in support of their mission of making the world a more hospitable place for people regardless of sexual orientation, gender identity or health status. The awards serves multi
Bill to 'Revolutionize' HIV Testing Passes California Legislature Unanimously: Business Wire - August 12, 2008; -- AB 2899 (Portantino, D-Pasadena), Sponsored by AIDS Healthcare Foundation (AHF), Overhauls Counseling Model for HIV Testing Programs; Bill Eliminates Outdated One Size Fits All Approach for More Prudent Public Health Approach SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-gover
One(R) Condoms Challenges Presidential Candidates to Get in Bed with Condoms: Business Wire - August 12, 2008; -- Company Delivers More Than 100,000 Condoms to Campaigns; Encouraging Distribution in Support of Comprehensive Sexual Education BOSTON--In response to a recent report by the Centers for Disease Control regarding a sharp increase in HIV infection rates in the United States , One(R) Condoms has issued a bold challenge
Dicerna Pharmaceuticals' Co-founders Publish Studies Describing Novel Approaches to Maximizing Dicer-Substrate Small Interfering RNAs (DsiRNAs): Business Wire - August 12, 2008; CAMBRIDGE, Mass.--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), today announced key studies highlighting the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs). Th
Inhibitex Reports Second Quarter 2008 Financial Results and Highlights: Business Wire - August 12, 2008; ATLANTA--Inhibitex, Inc. (NASDAQ:INHX) today announced its financial results for the second quarter ended June 30, 2008. We are pleased and encouraged by the measurable progress we have made in all three of our core antiviral development programs during the first half of 2008, most notably the clinical advancement of o
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults: Business Wire - August 11, 2008; - Important New Treatment Option for Millions in United States Affected by Life-Threatening Liver Disease - FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration ( FDA ) has granted marketing approval for
Allion Healthcare to Present at Noble Financial Equity Conference: Business Wire - August 11, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 8:30 a.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada. Mike Moran, Allion s Chairman, President and Chief Executive Officer and Russ Fichera
Argos Therapeutics to Discuss Automated Manufacturing Process for its Arcelis(TM) Personalized Immunotherapy Platform: Business Wire - August 11, 2008; -- Presentation at the Cambridge Healthtech Institute s Advances in Cancer Vaccines Conference DURHAM, N.C.--Argos Therapeutics today announced that Dr. Fred Miesowicz, Ph.D., Chief Operating Officer, will present details on the Company s automated manufacturing process for its Arcelis(TM) platform, a technology for cr
NanoViricides, Inc. Reports that HIVCide-I Was Significantly Superior to the Current Anti-HIV Three Drug Cocktail Standard: Business Wire - August 11, 2008; -- The Novel Mechanism of Action of HIVCide-I Defines a New Class of Anti-HIV Drugs WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), (the Company ) said that additional biological tests and data analysis have shown that animals treated with its lead anti-HIV drug candidate, HIVCide(TM)-I, demonstrated a substa
Mexico City AIDS 2008: Luminaries Call For Ending AIDS through A Vaccine at Global Conference: Business Wire - August, 7 2008; MEXICO CITY--XVII International AIDS Conference - Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year s International AIDS Conference (IAC) held in Mexico City. Unlike previous IAC conferences, this year s event did not have a plenary sessi
CORRECTING and REPLACING CASTLE Data Showed Boosted REYATAZ® (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender: Business Wire - August 5, 2008; -- CASTLE gender subanalysis provides largest scale information to date about boosted protease inhibitor-based combination HIV therapy in treatment-naive women Correction by... Bristol-Myers Squibb Company MEXICO CITY--Please replace the release with the following corrected version due to multiple revisions. The co
Resetting Expectations in the Search for an AIDS Vaccine: Business Wire - August 5, 2008; -- In its AIDS Vaccine Blueprint 2008, IAVI proposes a series of interim milestones to help overcome the biggest challenges facing the AIDS vaccine field today MEXICO CITY--With the release of its AIDS Vaccine Blueprint 2008 at the International AIDS Conference today in Mexico City, the International AIDS Vaccine Initi
ISENTRESS(R) (raltegravir), Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts Through 96 Weeks in Treatment-Naive HIV-Infected Patients When Taken With Other Anti-HIV Medicines: Business Wire - August 5, 2008; -- Efficacy and Tolerability Profile Consistent With Data Seen in Approved Treatment-Experienced Indication WHITEHOUSE STATION, N.J.--ISENTRESS(R) (raltegravir), Merck & Co. , Inc. s first-in-class integrase inhibitor, in combination with two other anti-HIV medicines, reduced HIV viral load to undetectable levels (
BRISTOL-MYERS SQUIBB LAUNCHES SECURE THE FUTURE(R) TECHNICAL ASSISTANCE PROGRAM TO OPTIMIZE COMMUNITY SERVICES FOR COMPREHENSIVE HIV MANAGEMENT IN SUB-SAHARAN AFRICA: Business Wire - August 5, 2008; -- Key learnings from ongoing SECURE THE FUTURE initiatives to be presented at International AIDS Conference in Mexico City MEXICO CITY-- Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb Foundation announced today the launch of the SECURE THE FUTURE(R) Technical Assistance Program (TAP), an innovat
Stanford Study Finds HIV Drug Can Persist in Mothers' Milk, Increasing Risk to Them and Their Babies International AIDS Conference: Business Wire - August 5, 2008; STANFORD, Calif.--A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of
Argos Therapeutics' Arcelis(TM) Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial: Business Wire - August 5, 2008; -Positive Immune Response Data Presented at XVII International AIDS Conference- XVII International AIDS Conference DURHAM, N.C.--Argos Therapeutics today announced the presentation of positive immune response data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy
Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe: Business Wire - August 4, 2008; -- A new innovative therapeutic immunization designed to help existing HIV and AIDS patients enjoy prolonged drug - and side effect - free periods was announced today at the AIDS 2008 conference in Mexico City MEXICO CITY--Bionor Immuno today announced that it has advanced its efforts to develop the first HIV therapeut
AHF Praises Merck for AIDS Drug Price Freeze in US: Drug Company to Keep Price of Second-line AIDS Therapy Isentress (raltegravir) at 2007 Launch Price for ADAP: Business Wire - August 4, 2008; MEXICO CITY--AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide—including at four free treatment clinics in Mexico—lauded Merck & Company over it intention to freeze the price on its second-line antiretrovi
President Calderon Lifts Regulation Requiring AIDS Drug Companies to Have Manufacturing Plants in Mexico in Order to Sell Generic Meds: Business Wire - August 4, 2008; -- Coalicion de Activistas por el Accesso Universal en VIH/SIDA and AIDS Healthcare Foundation Cheer President s Action; Vow to Press Government to Ensure Affordable Generic AIDS Drugs MEXICO CITY--(On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon
Marchers Demand AIDS Testing and Treatment as Mexico City AIDS Conference Convenes; Photos Are Available on Business Wire's Web Site and AP PhotoExpress: Business Wire - August 3, 2008; MEXICO CITY--AIDS Healthcare Foundation: Mexico City: AIDS Marchers Demand Testing and Treatment Thousands of AIDS advocates crowded the streets of Mexico City today in a multinational march and rally, spearheaded by AIDS Healthcare Foundation, to demand Universal AIDS Action Now. In a spirited march that began at Plaz
CDC Numbers: HIV Prevention in US a Failure; AHF Calls for $200M to Test 10M People: Business Wire - August 3, 2008; MEXICO CITY-- These numbers are a scathing indictment of how profoundly U.S. and CDC HIV prevention efforts have failed, said Michael Weinstein, President of AIDS Healthcare Foundation, the U.S. largest AIDS organization, in a statement from Mexico City. Despite the way the CDC is spinning these new numbers-which AHF h
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries: Business Wire - August 1, 2008; -- - Agreement Includes Countries in Latin America and the Asia-Pacific Region - - Under Agreement, Gilead Will Lead Regulatory and Distribution Processes - FOSTER CITY, Calif. & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Gilead Sciences , Inc. (Nasdaq:GILD) and Merck & Co. , Inc. (NYSE:MR
Flowers Heritage Foundation to Present at International AIDS Conference in Mexico City, Mexico: Business Wire - August 1, 2008; -- Executive Director Greg Edwards to Present Findings on Current and Re-occurring Issues that Confront Implementation of Effective HIV/AIDS Responses in the United States XVII International AIDS Conference -- WHAT: The HIV/AIDS crisis in the United States produces almost daily discussion and the never-ending publicati
AIDS Healthcare Foundation to Preview AIDS Advocacy March and Events Set for Mexico City's AIDS Conference: Business Wire - July 31, 2008; -- Thousands of AIDS Advocates to March Sunday for Universal AIDS Action Now MEXICO CITY--AIDS Healthcare Foundation: Key Events Include: * AIDS MARCH & RALLY, Sunday, August 3rd-March Demanding Universal AIDS Action Now Proceeds from Plaza de la Revolucion to Zocalo Plaza, Starts at 3pm * AIDS Satellite Session- G
Bush Signs Historic Global AIDS Bill Which Will Save At Least Five Million Lives: Business Wire - July 30, 2008; -- AHF Advocacy Efforts Helped Keep PEPFAR s Focus on Providing Lifesaving Treatment; Graph Shows How Funding Will Save Five to Seven Million Lives Over the Next Five Years WASHINGTON--AIDS Healthcare Foundation (AHF), hailed President Bush for signing legislation to re-authorize PEPFAR (the President s Emergency Plan
Remarks by the President and the First Lady at the Signing of H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008: Business Wire - July 30, 2008; WASHINGTON--East Room 2:57 P.M. EDT MRS. BUSH: Welcome, everyone, to the White House. Thank you all very much for coming for this signing of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008. I m so glad you all are here. Americans
Fact Sheet: A Historic and Lifesaving Commitment to Fight HIV/AIDS: Business Wire - July 30, 2008; -- President Bush Signs Bipartisan Legislation to Reauthorize PEPFAR to Combat Global HIV/AIDS WASHINGTON--Today, President Bush signed into law H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. This legislation responds to the P
President Calderon Meets with 50 Mexican Non-Governmental Organizations; Commits to Making Lower AIDS Drug Pricing a Priority for National Government: Business Wire - July 29, 2008; -- AIDS Drugs Cost 30 Times as Much in Mexico as in Other Latin American Countries; President Also Commits to Help Work to Overcome Barriers to Access to Care and Treatment -- Coalicion de Activistas por el Accesso Universal en VIH/SIDA Hails Meeting, Vows to Work with President to Obtain Affordable AIDS Drug Pricing a
Nutra Pharma Announces Completion of Clinical Study in Adrenomyeloneuropathy (AMN): Business Wire - July 29, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc., has successfully completed the Phase IIb/IIIa clinical trial of its leading drug candidate for neu
Half-yearly Report: A&D PHARMA HOLDINGS N.V.: Business Wire - July 29, 2008; INTERIM REVIEWED CONDENSED CONSOLIDATED FINANCIAL RESULTS FOR THE 6 MONTHS ENDED 30 JUNE 2008 28% year-on-year growth in consolidated sales 41% year-on-year growth in Wholesale revenue 14% year-on-year growth in Sales & Marketing revenue 27% year-on-year growth in Retail revenue 51% year-on-year increase in normali
Panacos to Present Clinical Data on Bevirimat at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy: Business Wire - July 28, 2008; -- 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) today announced the Company s first-in-class HIV-1 maturation inhibitor, bevirimat, will be the subject of a poster and an oral presentation at the 48th Interscience Conference
CytoDyn on Target with Target for Electronic FDA Application: Business Wire - July 28, 2008; GLORIETA, N.M. & NEW YORK--CytoDyn, Inc. (Pink Sheets:CYDY) has selected Target Health, Inc. for the preparation and electronic filing of CytoDyn s upcoming FDA application using Target Health s proprietary e*CRF(R) system. The advantage of Target Health is based on its core expertise in regulatory affairs and clin
Gustavo Cisneros: Miss Universe 2008: Another Triumph for Venezuelan Women: Business Wire - July 28, 2008; CARACAS, Venezuela--Gustavo Cisneros, Chairman and Chief Executive Officer of the Cisneros Group of Companies, said today that the triumph of Dayana Mendoza, Miss Venezuela 2007, in the Miss Universe pageant held on July 14 is yet another of the many triumphs of Venezuelan women in all areas of public life. In an inter
Radio Address by the President to the Nation: Business Wire - July 26, 2008; WASHINGTON--THE PRESIDENT: Good morning. This week, Congress voted to expand a vital program that is saving lives across the developing world -- the Emergency Plan for AIDS Relief, also known as PEPFAR. I thank members of Congress from both sides of the aisle for working with my Administration to pass this important bi
Press Briefing by Dana Perino: Business Wire - July 24, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:43 P.M. EDT MS. PERINO: A special welcome to the Frattos. A couple of announcements, so bear with me here. In his speech on the freedom agenda earlier this morning you heard the President discuss PEPFAR, which is the President s Emergency Plan for AIDS Relief. He noted
Congress Approves Global AIDS Bill Which Will Save Five to Seven Million Lives: Business Wire - July 24, 2008; -- AHF Advocacy Efforts on Capitol Hill Helped Keep PEPFAR s Focus on Providing Lifesaving Treatment; Bill Moves on to President s Desk for Signature WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 79,000 individuals in 20 countries worldwide, lauded the U.S. H
Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth: Business Wire - July 24, 2008; Reports Broad-Based Net Sales Growth of 16% from Continuing Operations * Records Pre-Tax Earnings from Continuing Operations of $1,221 Million representing an Increase of 24% from Second Quarter 2007 * Posts Second Quarter 2008 GAAP EPS from Continuing Operations of $0.36 Compared to $0.30 in 2007, an Increase of 20%,
ISENTRESS(r) (raltegravir), Merck's First in Class Integrase Inhibitor, Suppressed HIV-1 Viral Load and Increased CD4 Cell Counts through 48-Weeks in Treatment-Experienced Adult Patients When Taken with Other Anti-HIV Medicines, New England Journal of Medicine Reports: Business Wire - July 23, 2008; In Additional Subgroup Analysis, ISENTRESS Helped to Increase CD4 Cell Counts and Decrease Viral Load in Patients Predicted to be Poor Responders WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ISENTRESS(r) (raltegravir), Merck s first-in-class HIV-1 integrase inhibitor, suppressed HIV-1 viral load and increased CD4 cell co
Panacos to Report Second Quarter Results and Provide Development Update: Business Wire - July 23, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will report its financial results for the second quarter of 2008 after the U.S. Financial Markets close on Wednesday, July 30, 2008. Following the announ
Celera Corporation Reports Fourth Quarter and Fiscal 2008 Results: Business Wire - July 23, 2008; ALAMEDA, Calif.--Celera (NASDAQ:CRA) today reported net revenues of $43.4 million for the fourth quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. The fourth quarter fiscal 2008 results included net revenues from Berkeley HeartLab, Inc. (BHL) and Atria Genetics Inc., which were acquired durin
New Report Estimates That South Africa Pharmaceuticals and Healthcare Market Was Worth US$3.03bn in 2007 and Should Reach US$4.41bn By 2012: Business Wire - July 23, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b0eecf/south_africa_p harm) has announced the addition of the South Africa Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. South Africa Pharmaceuticals and Healthcare Report provides independent forecasts and compe
Allion Healthcare Announces Date of Second Quarter 2008: Financial Results and Conference Call: Business Wire - July 23, 2008; MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended June 30, 2008, after the close of U.S. financial markets on Thursday, August 7, 2008. An accompanying conference call to discuss the results will be held at 5:00 p.m. ET; on Th
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vaccine with Funding from Wellcome Trust and Aeras Global TB Vaccine Foundation: Business Wire - July 23, 2008; -- Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide (pounds)8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan drug designation by the European Medicines Agency (EMEA) -- If successful, MVA85A would
Gilead Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV: Business Wire - July 22, 2008; -- Trial Will Assess Non-Inferiority of Once-Daily Elvitegravir Compared to Twice-Daily Raltegravir FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced that it has begun enrolling patients in a Phase III clinical trial of its investigational antiretroviral agent elvitegravir (GS 9137), a novel or
AHF Chart Shows How Senate Global AIDS Bill Will Save Five to Seven Million Lives: Business Wire - July 21, 2008; --As It Stands, Senate PEPFAR Bill Raises Global AIDS Treatment Goals in Proportion to Spending Increases on HIV/AIDS; Bill Also Requires PEPFAR to Examine Per-Patient-Spending to Increase Treatment Efficiencies WASHINGTON--A chart prepared by AIDS Healthcare Foundation (AHF) (www.aidshealth.org), which provides AIDS c
Trimeris Reports Second Quarter 2008 FUZEON(R) Sales Results: Business Wire - July 21, 2008; DURHAM, N.C.--Trimeris, Inc. (NASDAQ:TRMS) today announced worldwide net sales of FUZEON for the second quarter of 2008 were $38.3 million, down 38 percent from $62.0 million in the second quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the second quarter of 2008 were $16.1 million, down 51 percent from
FDA Grants Clearance for Celera's ViroSeq(R) HIV-1 Genotyping System Software v2.8: Business Wire - July 18, 2008; ALAMEDA, Calif.--Celera (NASDAQ:CRA) today announced that it has received marketing clearance from the U.S. Food and Drug Administration for its 510(k) submission of the ViroSeq HIV-1 Genotyping System Software v2.8. The ViroSeq HIV-1 Genotyping(TM) System is designed to detect mutations in the HIV-1 viral genome that
WikiAnswers.com to Run AnswerThon(TM) for Charity July 26-27, 2008: Business Wire - July 17, 2008; NEW YORK--Answers Corporation (NASDAQ: ANSW), creators of the leading answer engine offering reference site Answers.com(R) and social knowledge Q&A site WikiAnswers.com(TM), today announced its summer Charity AnswerThon, to be held July 26 - 27, 2008. The AnswerThons, held a few times each year, are organized onlin
By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals and Healthcare Market - Brazil Pharmaceuticals and Healthcare Report Q2 2008: Business Wire - July 16, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/0af28c/brazil_pharmac euti) has announced the addition of the Brazil Pharmaceuticals and Healthcare Report Q2 2008 report to their offering. The Brazil Pharmaceuticals and Healthcare Report provides independent forecasts and competitive i
American Sexual Behavior: Demographics of Sexual Activity, Fertility, and Childbearing Brings You the Often Surprising Facts about Reproductive Health: Business Wire - July 16, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/8952bc/american_sexua l_be) has announced the addition of the American Sexual Behavior: Demographics of Sexual Activity, Fertility, and Childbearing report to their offering. To create this ground-breaking volume, the New Strategist edito
Statement by the President: Business Wire - July 16, 2008; WASHINGTON--I thank the Senate for the strong, bipartisan vote today to pass important, life-saving legislation reauthorizing the President s Emergency Plan for AIDS Relief (PEPFAR). I appreciate the efforts of Majority Leader Reid, Senators Biden and Lugar, and all other Senators from both sides of the aisle who came
AHF Treatment Proposal Accepted by US Senate: Global AIDS Bill Will Save 5 Million Lives: Business Wire - July 16, 2008; -- Senators Reference AHF s African AIDS Treatment Clients Visits to Capitol Hill in Remarks on Bill; Delegations of Doctors and AIDS Patients From Africa Met With Over 70 Senate Offices During Past Three Months to Push Legislators to Keep Focus on Lifesaving Treatment WASHINGTON--AIDS Healthcare Foundation (AHF) (www.
Research and Markets: 'American Health: Demographics and Spending of Health Care Consumers' Focuses on Health Care Consumers Rather Than Industry Statistics: Business Wire - July 16, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/a513bf/american_healt h_d) has announced the addition of the American Health: Demographics and Spending of Health Care Consumers, 2nd Edition report to their offering. Because health care is one of the largest industries in the
Remarks by President Bush and President Compaore of Burkina Faso in Photo Opportunity: Business Wire - July 16, 2008; WASHINGTON--Oval Office 11:18 A.M. EDT PRESIDENT BUSH: Mr. President, thank you for coming. I first started my conversation with the President by complimenting him on his leadership in the United Nations and in the region. You ve been a constructive force for peace and stability. And we talked about
Cytheris Receives (euro)1.5 Million ($2.3 Million) from OSEO for HCV Clinical Development Program: Business Wire - July 15, 2008; -- Highly Competitive Government Award for Paris Region Recognizes Potential of Interleukin-7 as an Immunotherapy PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that OSEO, France s national agency for industrial
Safe Haven Project Kicks Off Second Annual Capital to Capital Bike Tour: Business Wire - July 15, 2008; -- Cycling team takes three-day journey from Albany, N.Y. to Boston, MA. to raise awareness and funding on behalf of young people living with HIV and AIDS NORTHAMPTON, Mass.--The Safe Haven Project, Inc., a non-profit organization that strives to improve the physical, emotional and social well being of children and you
Clinical Labs in South Africa Look to Integration and Consolidation: Business Wire - July 15, 2008; CAPE TOWN, South Africa--NHLS laboratories in South Africa consist predominantly of stand-alone automated systems. IT support in the majority of these laboratories is poor and constrains the use of certain equipment. In addition, 250 nationwide laboratories are allowed public access to clinical services, especially CD4
Argos Therapeutics to Discuss Automated Manufacturing Process for Personalized Immunotherapy at IBC Next Generation Vaccines Conference: Business Wire - July 14, 2008; DURHAM, N.C.--Argos Therapeutics today announced that Tamara Monesmith, Director of Manufacturing and Process Development, will present details on the Company s automated approach to manufacturing personalized dendritic cell immunotherapies. The Company s advanced manufacturing process is complementary to its Arcelis(T
Pharmaceuticals and Healthcare Report Q2 2008: Independent Forecasts and Competitive Intelligence on Zimbabwe's Pharmaceuticals and Healthcare Industry: Business Wire - July 14, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/3b8522/zimbabwe_pharm aceu) has announced the addition of the Zimbabwe Pharmaceuticals and Healthcare Report Q2 2008 report to their offering. The Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competiti
FDA Approves Energex Systems, Inc. Non-Drug Therapy For HIV Research: Novel Approach to Creating Therapeutic Vaccine: Business Wire - July 14, 2008; ALLENDALE, N.J.--Energex Systems, Inc. announced today that it has been granted approval from the Federal Food and Drug Administration ( FDA ) to utilize its experimental HemoModulation™ therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load c
Minnesota AIDS Project Welcomes Actress and HIV Advocate Gloria Reuben to Minneapolis: Business Wire - July 11, 2008; - First in a series of three public forums on HIV - MINNEAPOLIS--The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, has assembled a diverse, all-star lineup for the 2008 Allan Spear Forum series that examines issues surrounding HIV policy. The first event will take place in Mi
CDC, Premier Healthcare Alliance Work to Eliminate Occupational Needlestick Injuries: Business Wire - July 9, 2008; -- Hospitals Average 1,000 Accidental Injuries Daily, Can Lead to Life-Threatening Infections; Sharps Injury Prevention Workbook and Tools to Educate Personnel on Best Practices CHARLOTTE, N.C.--More than 385,000 needlestick and other sharps-related injuries are sustained annually by hospital-based healthcare personnel
Samaritan's HIV Drug Granted IND from FDA: Business Wire - July 8, 2008; Samaritan Expects SP-6310 Study to Confirm Significant Positive Results of a Previously Conducted Phase I/II * Improvement in Immune Function * Improvement of Quality of Life LAS VEGAS--Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new
Growing Demand for Infectious Disease Diagnostics across East Africa: Business Wire - July 8, 2008; CAPE TOWN, South Africa--Infectious disease diagnostics markets across east Africa are expanding steadily. This is mainly due to the increasing number of patients on antiretrovirals (ARVs) and the scaling up of voluntary counselling and testing programmes in the region. New analysis from Frost & Sullivan (http://ww
SF Study: Streamlined Consent Increases HIV Testing Among High-Risk Populations, Notes AHF: Business Wire - July 7, 2008; Study Supports CDC s 2006 Recommendation for Elimination of Written Informed Consent in HIV Testing; California at Forefront of Push for Routine Screening of General Population LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increas
Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.: Business Wire - July 4, 2008; LUXEMBOURG & KALAMAZOO, Mich.--ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients: Business Wire - July 3, 2008; COLLEGEVILLE, Pa., & TARRYTOWN, N.Y.--Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission. RELIS
Statement by the President on 2008 G8 Summit: Business Wire - July 2, 2008; WASHINGTON--Rose Garden 10:31 A.M. EDT THE PRESIDENT: Good morning. Next week I m going to travel to Japan for the eighth and final G8 summit of my presidency. At recent summits, G8 countries have made pledges to help developing nations address challenges, from health care to education, to corruption. Now we need to sh
CytoDyn Begins GMP Manufacturing of Its First-In-Class AIDS Drug: Business Wire - July 2, 2008; LOS ANGELES--CytoDyn, Inc. (Pink Sheets: CYDY) has begun GMP manufacturing and humanization of Cytolin(C), a monoclonal antibody that uses the human immune system to control HIV infection. The murine version of this product, for which there is already considerable human experience, will be used for a fast, randomized,
Press Briefing on the President's Trip to Japan and the G8 Summit: Business Wire - July 1, 2008; -- Press Briefing by National Security Council Senior Director for Asian Affairs, Dennis Wilder; Assistant to the President for International Economic Affairs, Dan Price; and Chairman of the Council on Environmental Quality, James Connaughton on the President s Trip to Japan and the G8 Summit LITTLE ROCK, Ark.--Jam
Aethlon Medical Announces Second HIV/AIDS Treatment Site: Business Wire - July 1, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India . Aethlon previously disclosed plans to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which cau
RED to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa: Business Wire - June 30, 2008; Led by Don MacKinnon, Founder of Hear Music NEW YORK--In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this new model will create a new revenue stream for artists and labels
Diagnostic HYBRIDS Receives Third Frontier Grant for Development of Assays to Monitor Drug Resistance and Vaccine Production: Business Wire - June 27, 2008; ATHENS, Ohio--Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza
AIDS Healthcare Foundation: Criticism Mounts as CDC Delays Stark New HIV Data: Business Wire - June 26, 2008; -- Lancet Editorial, Remarks by Dr. Anthony Fauci Raise New Questions on HIV Numbers; Actions Highlight Failure of US HIV Prevention Efforts as CDC Continues to Stonewall Release of Crucial Data Expected to Show Far Higher Incidence of HIV Nationwide WASHINGTON--AIDS Healthcare Foundation (AHF) is calling upon the Cent
Allion Healthcare Announces Results of Annual Shareholders Meeting: Business Wire - June 26, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced the successful completion of it s annual meeting held on June 24, 2008 at which three new directors were elected to serve on its six member Board. The shareholders also approved the issuance of 6,125,448 shares of common stock reflecting the one-for-one c
Remarks by the President at Office of Faith-Based and Community Initiatives' National Conference: Business Wire - June 26, 2008; WASHINGTON--Omni Shoreham Hotel 12:59 P.M. EDT THE PRESIDENT: Thank you very much. Please be seated. (Applause.) How beautiful was that? From being a homeless mother of two to introducing the President of the United States . (Applause.) There has to be a higher power. I love being with members of the armies of compassi
Statement by Mrs. Laura Bush: Business Wire - June 26, 2008; WASHINGTON--National HIV Testing Day is an opportunity for Americans to increase their awareness of HIV/AIDS and get tested. More than one million Americans have HIV - and a quarter of them don t even know it. Through the Ryan White HIV/AIDS program, HIV/AIDS patients can receive treatment, including life-saving drugs,
OraSure Technologies and the National Association of People with AIDS Will Open the NASDAQ Stock Market on June 27 in Observance of National HIV Testing Day: Business Wire - June 26, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) and the National Association of People with AIDS (NAPWA) announced today that OraSure officials will be joined by Frank Oldham, Jr., President and CEO of NAPWA, and the Honorable Johnny Ford, Mayor of Tuskegee, Alabama and Director General of the World Conference
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine: Business Wire - June 26, 2008; -- Results of a Second Phase 1 Trial in Oncology Further Demonstrate the Potential of Interleukin-7 To Induce Dramatic and Prolonged CD4 and CD8 T Cell Expansion PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the
Press Briefing by Dana Perino: Business Wire - June 25, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:38 P.M. EDT MS. PERINO: Hello. One announcement for you. Tomorrow President Bush will deliver remarks at the Office of Faith-Based and Community Initiatives National Conference. During his speech he will highlight the Initiative s record of helping millions in need acro
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL® in Women Ages 27 through 45: Business Wire - June 25, 2008; WHITEHOUSE STATION, N.J.-- Merck & Co. , Inc. announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL® in women ages 27 though 45. The agency issued the letter to advise that it has
European Nucleic Acid-Based Amplification Reagents Markets for Clinical Applications: Business Wire - June 24, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/33e995/european_nucle ic_a) has announced the addition of Frost & Sullivan s new report European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications to their offering. Research Overview: This Frost & Sulliv
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D: Business Wire - June 24, 2008; -- The NITD and the TB Alliance s collaboration aims to move projects quickly from the research phase through the translational stage and into development Both partners will leverage their broad networks of expertise and resources to rapidly bring effective, simpler treatments to patients NEW YORK--The Global Alliance
Aethlon Medical Announces "First-In-Man" HIV/AIDS Treatment Study: Business Wire - June 24, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has entered into an agreement to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical device cre
Minnesota AIDS Project Recognizes National HIV Testing Day: Challenges Minnesotans to Know Their Status: Business Wire - June 23, 2008; MINNEAPOLIS--On June 27, in cities throughout the United States , organizations will mark National HIV Testing Day to encourage everyone to receive voluntary HIV testing and counseling to know his or her status. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, offers risk as
65 U.S. Mayors to Join OraSure Technologies and the National Association of People with AIDS in Fourth Annual 'Mayors Campaign against HIV™' for National HIV Testing Day: Business Wire - June 23, 2008; -- Record Number of U.S. Mayors Unite to Promote HIV Screening on June 27th BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ: OSUR) and the National Association of People with AIDS (NAPWA) announced today that more than 65 mayors and/or Department of Health offices in major metropolitan cities nationwide have committ
Mexican AIDS Activists March to Demand National State of Emergency Over Drug Prices and Access in Mexico: Business Wire - June 20, 2008; -- AIDS Healthcare Foundation Joins Over 60 Groups in Mexican AIDS Drug Advocacy Coalition; Marchers Call on Mexico s Secretary of Health to Step Up Action on AIDS Treatment and Drug Pricing MEXICO CITY--A group of over 150 AIDS Mexican advocates and activists held a passionate protest and advocacy march yesterday in M
Sybase 365 Supports Nelson Mandela Charities Launch of International SMS Campaign: Business Wire - June 19, 2008; -- Global Birthday Wishes Campaign for Mr. Mandela s 90th Birthday is First Truly Global Charity PSMS Service Ever Launched DUBLIN, Calif.--Sybase 365, a subsidiary of Sybase, Inc. (NYSE:SY), the global leader in mobile messaging services, today announced it has partnered with 46664, Nelson Mandela s HIV/AIDS global aw
2008 Presidential Medal of Freedom Citations: Business Wire - June 19, 2008; WASHINGTON--Today President George W. Bush awarded the Presidential Medal of Freedom to six individuals. The text of each recipient s citation reads as follows: Benjamin S. Carson, Sr., M.D. Dr. Benjamin Carson is a pioneer in pediatric neurosurgery, and his life is a testament to the power of education, hard work, and
Lab Express Offers $25 HIV Screening in Honor of National HIV Testing Day: Annual Test Recommended for Singles Who Are Sexually Active: Business Wire - June 18, 2008; PHOENIX--Lab Express, Arizona s largest independent medical testing company, is cutting the cost of their 10 minute HIV screening to just $25 (typically $89) from June 23rd to June 27th in honor of National HIV Testing Day. Doctors recommend that anyone who is sexually active and not in a monogamous relationship should
GRANT ANNOUNCEMENT: M·A·C AIDS Fund South Africa Marks Largest Ever One-Time Gift with One Million Rand to Local Charities: Business Wire - June 18, 2008; --Grant-Making Part of Week-long Giving, HIV Awareness Activities in Region from Top Global Funder --MAF: WHAT Two South African AIDS charities received a boost from the M·A·C AIDS Fund with the announcement today of two 500 000R grants, the single largest one-time gift from the South Africa affiliate of the global fun
Community Leaders Forge New Approach to HIV Prevention as Part of M·A·C AIDS Fund Leadership Initiative: Business Wire - June 18, 2008; --Twelve S. Africans Bring Columbia University, UCLA Fellowship Training to Local AIDS Programs; Gather in Johannesburg to Discuss Stigma, Gender Inequality --M·A·C AIDS Fund Marks $125M in Global Giving JOHANNESBURG, South Africa--HIV among imprisoned juveniles, teenagers and the Muslim community headlined a discussio
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection: Business Wire - June 17, 2008; * FUSILEV(TM) Launch Expected in Mid-August 2008 * FUSILEV(TM) NDA Approved by the FDA On March 7th, 2008 IRVINE, Calif.--Spectrum Pharmaceuticals, Inc., (NasdaqGM: SPPI) today announced the selection of FUSILEV(TM) (levoleucovorin) for injection as the trade name for levoleucovorin, the company s proprietary drug whic
Nationwide Data Indicate a Very High Degree of Accuracy for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test with Oral Fluid: Business Wire - June 16, 2008; -- Nationwide Accuracy for 2007 Through May 2008 of 99.8% Reported From Over 400 Testing Sites and More Than 250,000 Tests BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that aggregate nationwide performance data for 2007 and the first five months of 2008 indicate that its widely used rapid HI
NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model: Business Wire - June 16, 2008; -- Results Better Than Combination Therapy in Double-Blind Animal Study WEST HAVEN, Conn. -- NanoViricides, Inc. (OTC BB: NNVC.OB), (the Company ) said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV combo cockta
AHF to Dr. Fauci and the CDC: "Show Us the AIDS Numbers": Business Wire - June 11, 2008; -- U.S. s Largest AIDS Organization Demands Immediate Release of New AIDS Data Referred to By NIAIDS Director Dr. Anthony Fauci at U.N. AIDS Meeting Showing Higher Rate of Infection, Calls for Massive Increase in HIV Testing Nationwide NEW YORK--AIDS Healthcare Foundation (AHF) is calling for the immediate release of t
Viral Genetics Announces Expanded License with University of Colorado and V-Clip Pharmaceuticals: Progress to Date on Licensed HIV/AIDS Technology Leads to New Rights: Business Wire - June 11, 2008; AZUSA, Calif.--Viral Genetics (Pink Sheets: VRAL) subsidiary V-Clip Pharmaceuticals has expanded the existing Exclusive License Agreement with the University of Colorado by obtaining two Exclusive Option Agreements to acquire rights for treatment and detection of several forms of cancer including lung, breast, leukemia
California Scientists Sound Alarms about National Institutes of Health: Without Increased Funding, the State's Dominance and Public Health are Threatened: Business Wire - June 11, 2008; LA JOLLA, Calif.--The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, The National Institutes of Health: Fueling Healthcare Innovation in California, urging legislators to support increased funding for the National Institutes of Health (NIH) – the backbone of the biomedic
Panacos to Webcast its R&D Day on Wednesday, June 18th: Business Wire - June 11, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will broadcast its Research and Development Day over the internet on Wednesday June 18, at 12:00 pm ET. The meeting and webcast will be hosted by Alan W.
Panacos Presents Bevirimat Patient Response Predictors at the International HIV Drug Resistance Workshop: Business Wire - June 11, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), today announced factors that predict treatment response to bevirimat, a novel, oral HIV maturation inhibitor. The findings were described during multiple presentations at the 17th International HIV Drug Resistance Workshop in Sitges, Spain , con
MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand by What You Say': Business Wire - June 10, 2008; --Campaign Voiced by Superstar Kelly Rowland -- Causes Promotes Campaign to its 12 Million Subscribers LONDON & NEW YORK--MTV s Staying Alive Foundation, SpinVox and Causes on Facebook today announced the launch of their joint campaign, Stand by What You Say . The groundbreaking initiative encourages young people t
Micronics Receives NIH Grant to Advance Rapid Molecular Test for HIV Diagnosis: Development Effort Focuses on Point of Care Patient Testing: Business Wire - June 9, 2008; REDMOND, Wash.--Micronics, Inc., a leading provider of custom lab card design, development, and production services for the global health market, today announced that it has been awarded a $100,000 Small Business Innovation Research grant to advance its diagnostic test to detect Human Immunodeficiency Virus (HIV) at po
AHF's Public Health Division Celebrates Advances in the Fight Against HIV/AIDS with June 9th Re-Dedication Ceremony at Former Los Angeles AIDS Hospice: Business Wire - June 9, 2008; -- AHF s Chris Brownlie House, Formerly the First Licensed AIDS Hospice in the Nation, Now Serves Thousands as the Hub of US Largest AIDS Organization s Public Health Outreach, Providing HIV/STD Prevention, Testing and Counseling Services LOS ANGELES--AIDS Healthcare Foundation (AHF), operator of the largest non-govern
AIDS Thought Leaders Share Best Practices in HIV/AIDS Services Delivery as Disease Enters its Third Decade: Flowers Heritage Foundation Hosts Two Day Forum to Spur New Thinking in Addressing Epidemic: Business Wire - June 6, 2008; OAKLAND, Calif.--The Flowers Heritage Foundation, a non-profit dedicated to providing solutions for public health issues, today announced a two-day HIV/AIDS forum -- A Think Tank Experience - The Third Decade: New Directions and New Models in HIV Services -- on June 6 and June 7 in Oakland, CA. Key stakeholders and opi
OraSure Technologies to Present at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference: Business Wire - June 5, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference in New York City. The conference will be simultaneously webcast o
Remarks by President Bush and Prime Minister Jan Peter Balkenende of the Netherlands in Photo Opportunity: Business Wire - June 5, 2008; WASHINGTON--Oval Office 2:13 P.M. EDT PRESIDENT BUSH: Mr. Prime Minister, thanks for coming back. I enjoyed being with you. You represent a great country. You re a good friend of the United States of America. And I appreciate -- appreciate our candid discussion of a variety of issues. First, I want to thank you and
Remarks by the President at Ceremonial Groundbreaking of United States Institute of Peace: Business Wire - June 5, 2008; WASHINGTON--Navy Hill 10:49 A.M. EDT THE PRESIDENT: Thank you, all. Please be seated. Mr. Secretary, thank you for your kind introduction, and thank you for inviting me to join you to break ground for the United States Institute of Peace s new home. I m really pleased to be here. I appreciate what you do to resolve con
CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug: Business Wire - June 5, 2008; LOS ANGELES--Following a management meeting in San Francisco on June 7, representatives of CytoDyn, Inc. (Pink Sheets: CYDY) will be meeting with Principle Investigator Dr. Jay Lalezari at Quest Clinical Research to finalize the Company s strategy for a Phase II trial of Cytolin(R). An immune therapy that uses the huma
ExxonMobil Receives 2008 Malaria Award from Global Business Coalition: Nine Businesses to be Honored for Fighting Diseases: Business Wire - June 4, 2008; IRVING, Texas--Exxon Mobil Corporation (NYSE:XOM) has been awarded the 2008 Malaria Award by the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria in recognition of the corporation s Africa Health Initiative and its role in the battle against malaria. The prospects for winning the fight against global epi
Randy Jordan Begins as New CEO at HOPE worldwide: Founders Hand Over the Reins at Global Summit: Business Wire - June 4, 2008; WAYNE, Pa.--HOPE worldwide co-founders, Robert and Patricia Gempel, transferred their leadership roles to Randy Jordan , the global charity s chief operating officer, during the organization s annual Global Summit in May. Building on 12 years of senior leadership experience with HOPE worldwide, Jordan begins his new ro
South African Healthcare Industry: Emerging Trends and Future Prospects: Business Wire - June 4, 2008; PALO ALTO, Calif.--The Healthcare Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the South African healthcare industry to be held on Wednesday, June 11, 2008 at 8:00 a.m. PST. After 1994, South Africa transformed the healthcare system with a clear political comm
Avexa Collaborates With TargetDrug on HCV Program: The Company Also Provides an Update on ATC Phase III Trials: Business Wire - June 4, 2008; MELBOURNE, Australia--Australian biotechnology company Avexa Ltd (ASX:AVX) announced today that it will collaborate with TargetDrug on its Hepatitis C virus (HCV) program. The focus will be on the development of novel lead inhibitors of HCV replication. The Company also provided an update on the progress of its Apricit
Boehringer Ingelheim, Gilead Agree to AIDS Drug Price Freeze: Business Wire - June 3, 2008; -- AIDS Healthcare Foundation Urges Drug Giants Merck, Tibotec, Pfizer and Others to Follow Suit, Suspend Price Increases and Expand Access to Lifesaving Antiretroviral Medications LOS ANGELES--AIDS Healthcare Foundation (AHF) -- the largest US-based AIDS organization and operator of free AIDS treatment clinics in the
Vertex Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million: Business Wire - June 3, 2008; CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has sold its rights to future royalties in Lexiva(R) and Agenerase (R) under its 1993 license agreement with GlaxoSmithKline plc (GSK) in the field of HIV protease inhibitors
Search for an HIV Vaccine Continues Despite Setbacks: Fitness & Health III, Wellness: Business Wire - June 3, 2008; --A mood of deep pessimism has spread among the international community of AIDS scientists following last year s trial failure of a promising Merck vaccine. This was only the latest in a series of setbacks in the twenty-year struggle to develop an HIV vaccine. The passion for finding an HIV vaccine resonates strongly a
AHF Cheers Washingon Post Nod to Senator Coburn (R-OK) on Saving More Lives Through PEPFAR: Business Wire - June 2, 2008; --Sunday Editorial Concedes the Senator Has a Point in Striving to Preserve the Bill s Focus on Treatment --AHF Calls for Treatment Goal Increase Equal to Funding Increase. The Results? Four Million Additional Lives Saved WASHINGTON D.C.--AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in t
Converse (PRODUCT) RED(TM) Debuts Its Fall/Holiday 2008 Converse 1HUND(RED) Artists and African Canvas Footwear Collections: Business Wire - June 2, 2008; -- Converse s Year-Long Global Curation Project Includes Limited Edition Designed Shoes And MAKE MINE RED Design-Your-Own Options In Support of Converse (PRODUCT) RED NORTH ANDOVER, Mass.--Converse debuts the second 1HUND(RED) Artists footwear collection for Fall/Holiday 2008, the brand s unprecedented year-long global
VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data: Update at American Society of Gene Therapy Annual Meeting: Business Wire - May 30, 2008; GAITHERSBURG, Md.--VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present additional results from its Phase II trial of VRX496, an investigational gene therapy for the treatment of AIDS, at the 2008 American Society of Gene Therapy Annual Meeting in Boston, Ma
'Shame on Merck': Drug Giant Blasted for Steep AIDS Drug Prices in Mexico in New US Print Ad Campaign by AHF: Business Wire - May 29, 2008; --Newspaper Ads in New Jersey, New York s Village Voice and the Washington Blade Criticize Merck for Charging Mexico Six Times More Than Other Latin American Countries for its Key AIDS Drug, Stocrin LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments global
Yissum Introduces Novel Device for Improved Saliva Based Medical Diagnostics: Technology Presented at ILSI BioMed Israel 2008 conference - ILSI-Biomed Israel 2008: Business Wire - May 27, 2008; TEL AVIV, Israel-- Yissum, the technology transfer company of the Hebrew University of Jerusalem, introduced today a novel device that enhances the diagnostic value of saliva. Speaking at the Technology Transfer Session at the ILSI Biomed Israel 2008 conference Professor Aaron Palmon, from the Faculty of Dental Medicin
Inovio Biomedical Licenses Electroporation Delivery Technology to Leading U.S. Government Contractor, Advanced BioScience Laboratories, Inc.: License Anticipated to Aid the Development of DNA Vaccines for Chronic Infectious Diseases and Cancer: Business Wire - May 27, 2008; SAN DIEGO-- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that it has entered into a license agreement with Advanced BioScience Laboratories, Inc. (ABL) so that ABL may provide advanced electroporation delivery of
$50 Billion Needed for Global AIDS Control: Commentary by AIDS Healthcare Foundation President Michael Weinstein: Business Wire - May 23, 2008; WASHINGTON--As Congress considers the renewal of PEPFAR (the President s Emergency Plan for AIDS Relief), the successful US global AIDS program, over the coming weeks, AIDS Healthcare Foundation (AHF) President Michael Weinstein offers the following commentary regarding what is needed in the global fight against HIV/AI
National Education Summit to Tackle African-American HIV/STD Crisis: Business Wire - May 22, 2008; ALEXANDRIA, Va.--Black state board of education leaders from across the nation will meet to strategize about ways in which public schools can help address the HIV and STD crises among African-Americans and to highlight the clear link between risky sexual behaviors and academic performance on May 28-30, 2008 in Atlanta,
Independent Forecasts and Competitive Intelligence on Estonia's Pharmaceuticals and Healthcare Industry: Business Wire - May 22, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92547) has announced the addition of Estonia Pharmaceuticals and Healthcare Report Q2 2008 to their offering Poor healthcare has been seen as a weak link in Estonia s 15-year post-Soviet economic miracle , although the government has mad
Immunicon Corporation Presented Advances in Rare Cell Technology at ISAC XXIV International Congress, May 17-21, 2008: Business Wire - May 21, 2008; -- Presentations Highlight Advances in Rare Cell Image Cytometry in the Areas of HIV Monitoring, Identifying RSV Infections, Improved Detection of Circulating Tumor Cells and Automated F.I.S.H. Counting. HUNTINGDON VALLEY, Pa. & BUDAPEST, Hungary--Immunicon Corporation (OTCBB:IMMC) made several presentations at the
TherapyEdge (ABL group) and TCELS To Cooperate for the National HIV/AIDS Surveillance Program in Thailand Using The TherapyEdge-ViroScore System: Business Wire - May 20, 2008; LUXEMBOURG--The multi-centre and prospective surveillance program of HIV drug resistance emergence and transmission in Thailand starts in 2008 The Thailand Centre of Excellence for Life Sciences (TCELS, Bangkok (Thailand)), TherapyEdge Inc. (TE; Boston (MA)) and Advanced Biological Laboratories (ABL), S.A (
Samaritan's Last-Ditch Salvage Therapy SP-01A Fighting "HIV Drug Resistance," Issued US Patent: Business Wire - May 20, 2008; -Phase II Clinical Trials Prove Potent Activity for SP-01A as Salvage Therapy to Treat Ever Increasing HIV Drug Resistance -Patent Covers, 1. Composition of Anti-HIV Drugs and Anti-Cortisol Compounds and 2. Method for Decreasing the Side Effects of Anti-HIV Drugs in Humans LAS VEGAS--(BUSINESS WIRE)--Samaritan Pharmace
Fixed-Dose Combination Drugs for Leading Diseases Report Provides a Discussion of the History and Advantages of Fixed-Dose Combination Drug Products: Business Wire - May 20, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92368) has announced the addition of The Global Market for Fixed-Dose Combination Drugs for Leading Diseases to their offering. The Global Market for Fixed-Dose Combination Drugs for Leading Diseases analyzes products and applications of
Nutra Pharma Subsidiary, ReceptoPharm, Receives Approval to Begin Clinical Trials for the Treatment of Feline Leukemia Virus (FeLV): Business Wire - May 19, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc., has received approval from the Florida Department of Agriculture and Consumer Services to conduct
CytoDyn Appoints Dr. Nader Z. Pourhassan Chief Operating Officer: Business Wire - May 19, 2008; LOS ANGELES--CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Nader Z. Pourhassan, Ph.D., as its Chief Operating Office. Dr. Pourhassan was born in Tehran in 1963, immigrated to the United States in 1977, and became a U.S. citizen in 1991. He received his Bachelor of Science from Utah State University in 1985, his Master
Webcast to Showcase Saba Centra and The Hope Program-Globally Training Physicians in HIV Medicine: Attendees to Learn How to Facilitate Cost-Effective, Worldwide Learning and Collaboration: Business Wire - May 16, 2008; REDWOOD SHORES, Calif.--Saba (NASDAQ:SABA) the premier people management software and services provider, has announced that its customer, the HIV Online Provider Education (HOPE) Program, will be featured in an upcoming Saba Webcast titled, How Online Collaboration is Changing the World-The Use of Technology for Rapid,
AIDS Portrait Exhibit in Russell Rotunda Highlights Need to Preserve AIDS Treatment Focus in PEPFAR - 'AfricAlive: Portraits of Success': Business Wire - May 15, 2008; Despite Congress Tripling of PEPFAR Funding for Successful US Global AIDS Program, Current Re-authorization Bill Lacks Any Treatment Requirement, a Key Component to PEPFAR s Success MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5685774 --AIDS Healthcare Foundation: AfricAlive: Portraits of Succe
Allion Healthcare to Present at JMP Securities Research Conference: Business Wire - May 13, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will participate in the Seventh Annual JMP Securities Research Conference in San Francisco, May 21, 2008. Mike Moran, Allion s Chairman, President and Chief Executive Officer will give a Company presentation on Wednesday, May 21, 2008, at 4:30 PM
Senators Support African AIDS Delegation Call to Save Seven Million Lives through PEPFAR: Business Wire - May 12, 2008; -- Congress Triples Funding for Successful US Global AIDS Program in Re-authorization Bill, but Removes Requirement that Any Money Be Spent on Treatment, a Key Component of PEPFAR s Success --Senators Will Announce Effort to Preserve Treatment Priority in Legislation and Push to Increase PEPFAR s Treatment Goals; Up On
Ramsell Public Health Rx Awarded Colorado State Pharmaceutical Assistance Program Contract: Program to Help AIDS Patients with Much Needed Pharmaceutical Assistance: Business Wire - May 12, 2008; OAKLAND, Calif.--Ramsell Public Health Rx today announced that it will administer a full suite of Pharmacy Benefit Management (PBM) solutions for the Bridging the Gap, Colorado (BTGC) program, a State Pharmaceutical Assistance Program (SPAP) that covers the costs of a participant s Medicare deductible, co-payment and c
Virostatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection: Business Wire - May 12, 2008; SASSARI, Italy & PRINCETON, N.J.--Virostatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced it has initiated dosing of subjects in its five-arm, dose-ranging, proof of principle st
Argos Therapeutics Initiates Phase 2 Proof-of-Concept Trial for its Arcelis{TM} Personalized Immunotherapy Platform in HIV: Business Wire - May 12, 2008; DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a proof-of-concept clinical trial to test the efficacy of its AGS-004 therapy in improving immune control of viral replication in HIV-infected adults. AGS-004 is a product of the Company s Arcelis{TM} technology, a personalized, RNA-loaded dend
AHF Launches "YouTube" Campaign: "Congress-Save AIDS Treatment in PEPFAR": Business Wire - May 11, 2008; -- Jenny Boyce, a Mother Living with HIV/AIDS in Durban, South Africa , Tells the Story of How Treatment Saved Her Life --Lydia Nyide Speaks About Her 11-Year-Old Granddaughter Phumla Whose Life Was Saved by Treatment WASHINGTON--Today AIDS Healthcare Foundation (AHF), launched a YouTube video to press Congress to pr
Allion Healthcare Reports First Quarter 2008 Results: Business Wire - May 8, 2008; * Net sales for the quarter increased 10.7% to a record $65.3 million * Announces Opening of New Pharmacy in Seattle with Lifelong Aids Alliance * Announces settlement of Oris Litigation MELVILLE, N.Y.--(BUSINESS WIRE)--Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended March
Minnesota AIDS Project to Host 21st Annual AIDS Walk and Inaugural 10K Run: Business Wire - May 8, 2008; MINNEAPOLIS--Each year, the Minnesota AIDS Project hosts the largest HIV fundraiser in the state. The 2008 Minnesota AIDS Walk on May 18th will be the 21st annual event to raise crucial funds to support ongoing advocacy efforts, prevention education, and services for those living with HIV in Minnesota. A total of 325 n
Aethlon Medical Releases Smallpox Related Research Data: Business Wire - May 8, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today disclosed that researchers have completed in vitro studies that verify the ability of the Aethlon Hemopurifier{R} to effectively capture monkeypox virus (MPV). MPV represents a primary model to study candidate therapies for smallpox virus as research with human infect
OraSure Technologies Announces 2008 First Quarter Results: Business Wire - May 6, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.1 million for the three months ended March 31, 2008, compared to $20.1 million in revenues recorded for the three months ended March 31, 2007. Increased sales of the Company s O
Press Briefing by Dana Perino: Business Wire - May 6, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:41 P.M. EDT MS. PERINO: Hi, how is everybody? Two announcements for you. First of all, the President is pleased that the U.S.-Russian Agreement for Cooperation in the Field of Peaceful Uses of Nuclear Energy -- also known as a 123 Agreement -- was signed today in Moscow
OC AIDS Walk Aims for Million Mark: Business Wire - May 6, 2008; ANAHEIM, Calif.--With only a week away until OC AIDS Walk at Angel Stadium of Anaheim on Saturday, May 10th, event organizers are hopeful that the Walk will far exceed its goal of $750,000. Although past years has rendered it difficult for the Walk to raise over $600,000 at its former location on the campus of UC Irvin
Washington Wines Festival Announces "Wine Weekend" to Benefit Camp Korey, Hole in the Wall Camps and Washington Wine Education Foundation: First-Time Ever Exclusive Event to Feature Music Artists Vince Gill, Amy Grant and Lisa Loeb, Renowned Chefs and 50 of the Top Wineries of Washington State: Business Wire - May 6, 2008; CARNATION, Wash.--The Washington Wines Festival announced today the 2008 Wine Weekend to benefit Camp Korey and Hole in the Wall Camps. This exclusive event featuring two days of fun, relaxation and entertainment will be held July 11 & 12, 2008 at the future site of Camp Korey at Carnation Farm and will raise funds
Aethlon Hemopurifier{R} Effective in Capturing West Nile Virus: Business Wire - May 6, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced that pre-clinical studies have documented that the Aethlon Hemopurifier{R} is effective in capturing circulating West Nile Virus (WNV). The study data further supports the potential use of the Hemopurifier{R} as a broad-spectrum treatment against viral patho
NEW Clorox{R} Disinfectant is EPA Registered to Kill Both Known Types of MRSA - Including Community-Associated (CA-MRSA): Clorox{R} Pro Quaternary All-Purpose Disinfectant Cleaner Offers a One-Step Germ-Killing Solution for Professionals: Business Wire - May 5, 2008; OAKLAND, Calif.--While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers. In May, The Clorox Company will launch Clorox{R} Pro Quaternary A
Two New Hampshire Youth Honored for Volunteerism at National Award Ceremony in Washington, D.C.: Sarah Ferguson, Duchess of York, Pays Tribute to Young Heroes as Part of Four-Day Recognition Events: Business Wire - May 5, 2008; WASHINGTON--Two New Hampshire students, Aditya Ashok, 17, of Nashua and Brianna Hartford, 14, of Littleton were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth
Two Vermont Youth Honored for Volunteerism at National Award Ceremony in Washington, D.C.: Sarah Ferguson, Duchess of York, Pays Tribute to Young Heroes as Part of Four-Day Recognition Events: Business Wire - May 5, 2008; WASHINGTON--Two Vermont students, Zoe Isaacs, 16, of Sharon and Claire Trombley, 12, of Bristol were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth volunteers
Anti-HIV NanoViricide Drug Candidate Demonstrates Significant Therapeutic Efficacy in Animal Trials: Positive Initial Results Pave the Way for Definitive Follow-Up Studies: Business Wire - May 5, 2008; WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), said that its anti-HIV drug candidates demonstrated significant therapeutic efficacy in the recently completed preliminary animal studies. The studies were performed at a Bio-Safety Level 3 Laboratory (BSL-3) facility in Boston, MA. These mouse model studies wer
Indiana Religious Leaders Urge Obama and Clinton to Overhaul Foreign Aid: Business Wire - May 2, 2008; WASHINGTON--Today, Global AIDS Alliance announced that nine senior religious leaders from Indiana called on Senators Obama and Clinton to declare their support for an urgent overhaul of US foreign aid. At least 425 US soldiers, 15 of them from Indiana, have died in Afghanistan and
HHS Contract for Technical Management, Assistance on AIDS.gov Web Site Awarded to ICF International: Firm to Help Agency Enhance Features, Implement New Tools: Business Wire - May 1, 2008; FAIRFAX, Va.--ICF International (NASDAQ:ICFI) was selected by the U.S. Department of Health and Human Services, Office of HIV/AIDS Policy, to provide technical management and assistance to maintain and enhance its AIDS.gov Web site. Under the new contract, ICF will implement new media tools such as mobile technology, e
Panacos to Present at Deutsche Bank Health Care Conference: Business Wire - May 1, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Deutsche Bank Health Care Conference to be held from May 5-7, 2008 at The InterContinental Hotel in Boston, MA. Alan W. Dunton, M.D.,
SeraCare Seroconversion Panels with Extended Stability Improve Diagnostic Testing and Anti-viral Drug Discovery Opportunities: 25-year stability data presented at 24th Annual Clinical Virology Symposium: Business Wire - April 29, 2008; MILFORD, Mass.--SeraCare Life Sciences, Inc. (SRLS:PK) today presented data demonstrating that the Company’s seroconversion panels for HIV, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) remain stable for a minimum of 25 years. This extended shelf-life expands research opportunities for biopharmaceutical customers
BrowserMedia Launches New Website for The Alliance for Microbicide Development: Business Wire - April 29, 2008; BETHESDA, Md.--BrowserMedia announced today the launch of the new website for The Alliance for Microbicide Development, viewable at http://www.microbicide.org. The Alliance for Microbicide Development is the leading source for trusted information on microbicide research and development. BrowserMedia s design and inform
Allion Healthcare Appoints Chief Financial Officer: Business Wire - April 29, 2008; MELVILLE, N.Y.)--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced the appointment of Russell J. Fichera to the position of Senior Vice President and Chief Financial Officer, effective June 1, 2008. Russ brings to his new position a great base of experience in the healthcare sector, and a compelling record of lea
Spicy Pickle{TM} Teams With Dining Out for Life To Raise Funds For Project Angel Heart: Business Wire - April 29, 2008; --Spicy Pickle to Donate 25% of Sales on May 1st; Monies to be Used for Meals for People Living with Life-threatening Illnesses DENVER--The Spicy Pickle{TM} fast casual restaurant at 1298 S. Broadway today announced that 25% of their food sales on Thursday, May 1st will be donated to Project Angel Heart in support of t
Hope Blooms Eternal as New Website Brings Charitable Giving to the Facebook Generation:Hope Equity(R) revolutionizes philanthropy with one-stop charity shopping: Business Wire - April 28, 2008; LITTLE ROCK, Ark.--Facebook. MySpace. LinkedIn. The social networking trend is projected to grow by an estimated 43 percent annually over the next five years (according to Forrester Research). Now a new website is leveraging this social networking phenomenon to build online communities dedicated to helping the world ar
National Volunteer of the Year Takes to Capitol Hill This Week: Business Wire - April 28, 2008; ALEXANDRIA, Va.--Participating in AIDS Watch 2008, Catholic Charities USA s newly named National Volunteer of the Year is on Capitol Hill this week seeking a solid federal commitment to AIDS programs. Ray Suttles, a volunteer with Catholic Charities of Paterson s Hope House in New Jersey, was named Catholic Charities U
Sunday, April 27th: Actors Blair Underwood and Mario Cantone Join Thousands for Florida AIDS Walk: Business Wire - April 27, 2008; --Funds Raised Will Support Expanded HIV Testing and Statewide Medical Care --87,000 Floridians Are Infected With HIV/AIDS, South Florida Leads the Nation in New AIDS Cases --AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, April 27, 2008 Opening Ceremony: 9:15 a.m., Walk Begins: 10:00 a.m. Where:
Press Gaggle by Dana Perino and Admiral Ziemer: Business Wire - April 25, 2008; SOUTH KENT, Conn.--Aboard Air Force One En route Hartford, Connecticut 9:52 A.M. EDT MS. PERINO: Okay. We are on our way to Connecticut, and I have a special guest with me, Admiral Tim Ziemer, who I will turn over to in a second, because he heads up the President s Malaria Awareness Initiative and was with the First La
Fact Sheet: 2008 Malaria Awareness Day - President's Malaria Initiative is Spreading Hope and Saving Lives Across Africa: Business Wire - April 25, 2008; WASHINGTON--Today, President and Mrs. Bush commemorated the second annual Malaria Awareness Day and renewed America s commitment to lead the world in turning the tide against malaria in Africa and around the world. Yesterday, Mrs. Bush joined Members of Congress to announce the formation of the Congressional Malaria Ca
European Commission Approves Viread{R} for Chronic Hepatitis B: Important New Treatment Option for Millions of Europeans Affected by Life-Threatening Disease: Business Wire - April 25, 2008; FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the European Commission has granted marketing authorisation for Viread {R} ( tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B in all 27 member stat
Progenics and Wyeth Announce FDA Has Approved RELISTOR: First Drug for Opioid-Induced Constipation to Launch in United States: Business Wire - April 24, 2008; TARRYTOWN, N.Y. & COLLEGEVILLE, Pa.--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration ( FDA ) has approved RELISTOR™ (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-indu
Scientific Consensus on AIDS Vaccine Prospect is Bleak, Poll Reveals: "Substantial Minority" of Scientists' Polled Believe AIDS Vaccine May Never Be Developed: Business Wire - April 24, 2008; LOS ANGELES--Scientific consensus on the prospect for development of an effective preventive AIDS vaccine is bleak, according to the results of a poll of AIDS researchers and scientists which was released earlier today. The poll of AIDS scientists offered significant additional credibility to the recent public call by
Texas HIV Medication Program Awards State Pharmacy Assistance Program Contract to Ramsell Public Health Rx: Business Wire - April 24, 2008; -- Eligible AIDS/HIV Patients to Receive Assistance With Pharmaceutical Expenses OAKLAND, Calif.--Ramsell Public Health Rx today announced that the company will deliver its Pharmacy Benefit Management (PBM) solution to the Texas Department of State and Health Services (DSHS) for its new State Pharmacy Assistance Progra
Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread{R} for the Treatment of Chronic Hepatitis B: Business Wire - April 24, 2008; - Oral Presentations at EASL Following Recent CHMP Positive Opinion Support Viread as Potential New Treatment for Life-Threatening Liver Disease - EASL MILAN, Italy-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the presentation of detailed 72-week data from two pivotal Phase III clinical trials, St
Vertex Announces Positive Interim Results with Telaprevir-based Therapy in Genotype 1 Chronic Hepatitis C Patients who Failed to Achieve SVR with Previous Pegylated Interferon & Ribavirin Treatment: Business Wire - April 24, 2008; -Interim results to be presented in late-breaker poster presentation at EASL on April 24- -Significant early on-treatment viral response from patients who previously failed therapy- MILAN, Italy--In a late-breaker poster presentation at the 43rd Annual Meeting of the European Association for the Study of the Liver (EAS
Global AIDS Alliance Welcomes Call for Foreign Aid Overhaul: Business Wire - April 23, 2008; WASHINGTON--Today, the US Congress began a long overdue overhaul of the US foreign assistance process, which experts are saying is urgent if the US is to get good value-for-money in foreign aid. In the House of Representatives, the Foreign Affairs Committee heard from top experts who called for a Cabinet-Level Departme
New Zealand Delivers Personalized and Affordable, High Quality Medical Care for North American 'Medical Tourists': Business Wire - April 23, 2008; UCKLAND, New Zealand--New Zealand emerges as one of the most affordable options for Americans and Canadians seeking medical care and treatment in a first world environment where English is the primary language, reports Medtral New Zealand, a health care organization based in New Zealand (www.medtral.com) which coordina
Guardian Announces Release of Letter to Shareholders to Update Investors on Latest Strategic Achievements: Business Wire - April 23,